Healthcare’s relative resiliency to bear markets in conjunction with aging populations, medical innovations, and other tailwinds have prompted GPs to invest in retail care clinics, insurance providers, software and device developers, and other industry actors en masse—raising 2017’s total disclosed deal value to $42.6 billion, the highest level since 2007. However, as the volume of healthcare deals continues to rise to unprecedented heights, so have criticisms of private equity’s management of portfolio company care providers.
Two months after the General Data Protection Regulation (GDPR) came into effect, companies within and beyond the European Economic Area (EEA) are still grappling with how to comply with literal interpretations of… Continue Reading
Transparency has become the new normal in a society that demands greater accountability. Look no further than companies like Equifax, Wells Fargo, Chipotle, Uber and… Continue Reading
The Department of Justice (DOJ) and Securities and Exchange Commission (SEC) are investigating Biomet for alleged violations of the Foreign Corrupt Practices Act (FCPA), a… Continue Reading